Elevated basic fibroblast growth factor levels in patients with pulmonary arterial hypertension

Chest

Volumn 126, Issue 4, 2004, Pages 1255-1261

  Benisty, Jacques I ^a,d   McLaughlin, Vallerie V ^c   Landzberg, Michael J ^b   Rich, Jonathan D ^c   Newburger, Jane W ^b   Rich, Stuart ^c   Folkman, Judah ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD UNIVERSITY   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Angiogenesis; Growth substances; Pulmonary heart disease

Indexed keywords

FIBROBLAST GROWTH FACTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD EXAMINATION; CELL GROWTH; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; URINALYSIS;

EID: 6344285687     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.126.4.1255     Document Type: Article

References (18)

1. Folkman J. Clinical applications of research on angiogenesis. N Engl J Med 1995; 333:1757-1763
2. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1:27-31
3. Tuder RM, Lee SD, Cool CC. Histopathology of pulmonary hypertension. Chest 1998; 114:1:1S-5S
4. Pietra GG, Edwards WD, Kay JM, et al. Histopathology of primary pulmonary hypertension: a qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute Primary Pulmonary Hypertension Registry. Circulation 1989; 80: 1198-1206
5. Tuder RM, Chacon M, Alger L, et al. Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis. J Pathol 2001; 195:367-374
6. Klagsburn M, D'Amore P. Vascular endothelial growth factor and its receptors. Cytokine Growth Factors Rev 1996; 7: 259-270
7. Vlodavsky I, Folkman J, Sullivan R, et al. Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci U S A 1987; 84:2292-2296
8. Fishman AP. Clinical classification of pulmonary hypertension. Clin Chest Med 2001; 22:385-391
9. Rabinovitch M. Elastase and cell matrix interactions in the pathobiology of vascular disease. Acta Paediatr Jpn 1995; 37:657-666
10. Arcot SS, Fagerland JA, Lipke DW, et al. Basic fibroblast growth factor alterations during development of monocrotaline-induced pulmonary hypertension in rats. Growth Factors 1995; 12:121-130
11. Rich S, Bucana C, Giaid A, et al. Upregulation of basic fibroblast growth factor appears essential in the development of primary pulmonary hypertension [abstract]. J Am Coll Cardiol 2002; 39(suppl B):31B
12. Brogi E, Wu T, Namiki A, et al. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF only. Circulation 1994; 90:649-652
13. Breen EC, Johnson EC, Wagner H, et al. Angiogenic growth factor mRNA responses in muscle to a single bout of exercise. J Appl Physiol 1996; 81:355-361
14. Gustafsson T, Puntschart A, Kaijser L, et al. Exercise-induced expression of angiogenesis-related transcription and growth factors in human skeletal muscle. Am J Physiol 1999; 276: H679-H685
15. Nguyen M, Wantanabe H, Budson A, et al. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst 1994; 86:356-361
16. Thompson K, Rabinovitch M. Exogenous leukocyte and endogenous elastases can mediate mitogenic activity in pulmonary artery smooth muscle cells by release of extracellular-matrix bound basic fibroblast growth factor. J Cell Physiol 1996 Mar; 166:495-505
17. Stewart DJ, Levy RD, Cernacek P, et al. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease. Ann Intern Med 1991; 114:464-469
18. Channick RN, Rubin LJ. New and experimental therapies for pulmonary hypertension. Clin Chest Med 2001; 22:539-545